We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs
Company Overview We are partnering with a late-stage biopharmaceutical company developing a first-in-class therapy for cardio-metabolic disease, targeting the intersection of metabolic dysfunction and cardiovascular risk. With its lead asset advancing into Phase 3 development, the